IL1B and neoplasm: Several studies have demonstrated that IL-1β is able to activate both MMP9 and VEGF, thus stimulating tumor invasiveness and angiogenesis (Sasaki et al., 1998; Voronov et al., 2003; Yuzhalin and Kutikhin, 2015).